Skip to main content
$2.89 $0.04 (1.4%)

04:00 PM EST on 01/27/23

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $2.89 Mkt Cap $89.4M
Open $2.86 P/E Ratio 5.98
Prev. Close $2.89 Div. (Yield) $0.00 (0.0%)
Daily Range $2.83 - $2.92 Volume 72,027
52-Wk Range $2.26 - $7.35 Avg. Daily Vol. 136,586

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
35 Underperform
 

All-Star Players

3 Outperform
25 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (52.99)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (98.51)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: -54.74

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -79.55

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFbonefish (36.11) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -79.78

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (38.74) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Toprope101 99.89 3/12/2020 Underperform 5Y $12.76 -77.31% +59.13% +136.44 0 Comment
joaquingrech 98.51 3/27/2020 Underperform 5Y $9.19 -68.50% +59.40% +127.90 1 Comment
RayNobleEsq 99.98 4/21/2020 Underperform 5Y $13.46 -78.49% +48.21% +126.71 0 Comment
cvdynasty0 99.92 4/16/2020 Underperform 5Y $11.28 -74.34% +46.91% +121.25 0 Comment
dinasourneil 99.20 3/6/2020 Underperform 1Y $14.23 -79.66% +39.04% +118.69 0 Comment
evergreen5555 71.92 9/5/2017 11/4/2022 Underperform 5Y $5.91 -51.02% +65.91% +116.93 0 Comment
budyzerr 70.03 10/2/2017 Underperform 5Y $6.27 -53.83% +61.98% +115.81 0 Comment
kdakota630 30.09 4/17/2020 Underperform 3M $10.20 -71.62% +42.74% +114.36 0 Comment
chrispycrunch 89.20 3/5/2020 Underperform 5Y $14.65 -80.24% +33.72% +113.96 0 Comment
NorteClub 76.32 7/29/2020 Underperform 5Y $22.14 -86.92% +26.46% +113.39 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.